» Articles » PMID: 39062956

Mesenchymal Stem Cell-Derived Exosomes As Drug Delivery Vehicles in Disease Therapy

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Jul 27
PMID 39062956
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes are small vesicles containing proteins, nucleic acids, and biological lipids, which are responsible for intercellular communication. Studies have shown that exosomes can be utilized as effective drug delivery vehicles to accurately deliver therapeutic substances to target tissues, enhancing therapeutic effects and reducing side effects. Mesenchymal stem cells (MSCs) are a class of stem cells widely used for tissue engineering, regenerative medicine, and immunotherapy. Exosomes derived from MSCs have special immunomodulatory functions, low immunogenicity, the ability to penetrate tumor tissues, and high yield, which are expected to be engineered into efficient drug delivery systems. Despite the promising promise of MSC-derived exosomes, exploring their optimal preparation methods, drug-loading modalities, and therapeutic potential remains challenging. Therefore, this article reviews the related characteristics, preparation methods, application, and potential risks of MSC-derived exosomes as drug delivery systems in order to find potential therapeutic breakthroughs.

Citing Articles

Mesenchymal Stem-Cell-Derived Exosomes as Novel Drug Carriers in Anti-Cancer Treatment: A Myth or Reality?.

Harrell C, Volarevic A, Djonov V, Volarevic V Cells. 2025; 14(3).

PMID: 39936993 PMC: 11817634. DOI: 10.3390/cells14030202.


Mesenchymal stromal cell exosomes for drug delivery of prostate cancer treatments: a review.

Wang C, Feng Y, Rong X, Yan J, Lv B, Jiang H Stem Cell Res Ther. 2025; 16(1):18.

PMID: 39849570 PMC: 11755940. DOI: 10.1186/s13287-025-04133-8.


Stem cell therapy for the treatment of psychiatric disorders: a real hope for the next decades.

Villanueva R Front Psychiatry. 2025; 15():1492415.

PMID: 39839136 PMC: 11747238. DOI: 10.3389/fpsyt.2024.1492415.


Extracellular Vesicles from Mesenchymal Stem Cells: Potential as Therapeutics in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Zou X, Brigstock D Biomedicines. 2025; 12(12.

PMID: 39767754 PMC: 11673942. DOI: 10.3390/biomedicines12122848.


The potential of cellular homing behavior in tumor immunotherapy: from basic discoveries to clinical applications of immune, mesenchymal stem, and cancer cell homing.

Li D, Yang Y, Zheng G, Meng L, Shang L, Ren J Front Immunol. 2024; 15:1495978.

PMID: 39726590 PMC: 11669694. DOI: 10.3389/fimmu.2024.1495978.


References
1.
Coughlan C, Bruce K, Burgy O, Boyd T, Michel C, Garcia-Perez J . Exosome Isolation by Ultracentrifugation and Precipitation and Techniques for Downstream Analyses. Curr Protoc Cell Biol. 2020; 88(1):e110. PMC: 8088761. DOI: 10.1002/cpcb.110. View

2.
Abu N, Rus Bakarurraini N, Nasir S . Extracellular Vesicles and DAMPs in Cancer: A Mini-Review. Front Immunol. 2021; 12:740548. PMC: 8554306. DOI: 10.3389/fimmu.2021.740548. View

3.
Wubbolts R, Leckie R, Veenhuizen P, Schwarzmann G, Mobius W, Hoernschemeyer J . Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem. 2003; 278(13):10963-72. DOI: 10.1074/jbc.M207550200. View

4.
Sun Y, Liu G, Zhang K, Cao Q, Liu T, Li J . Mesenchymal stem cells-derived exosomes for drug delivery. Stem Cell Res Ther. 2021; 12(1):561. PMC: 8557580. DOI: 10.1186/s13287-021-02629-7. View

5.
Suchorska W, Lach M . The role of exosomes in tumor progression and metastasis (Review). Oncol Rep. 2015; 35(3):1237-44. DOI: 10.3892/or.2015.4507. View